Notify me when Allen Baharaff files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| GLMD | Galmed Pharmaceuticals Ltd. | Ordinary shares, NIS 1.80 par value per share | 2.6% | $60.5K | 44.1K | Allen Baharaff | Dec 31, 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|